同济堂
  Investor Relations
    Directors and Executive Officers
    Corporate Governance
    Stock Information
    Financial Reports
    SEC Filings
    Events
    Analyst Coverage
    Shareholder Services
     Download Investor Kit
     IR Contact
 
  Investor Relations You are here: Home -- Investor Relations  
 
  Corporate Profile
Tongjitang Chinese Medicines Company is a vertically integrated and profitable specialty pharmaceutical company focusing on the development, manufacturing,marketing and selling of modernized traditional Chinese medicine in China. ...More>>
 
Exchange: NYSE (US Dollar)
Price: 3.65
Change: +0.04
Volume: 5400
Data as of: 7/30/2010 4:00pm
 
 
 
 
  Jul 1, 2010 Tongjitang Files 2009 Annual Report on Form 20-F......
 
 
  Jun 18, 2010 Tongjitang Chinese Medicines Company Announces First Quarter......
 
 
  Jun 14, 2010 Tongjitang Chinese Medicines Company to Announce First Quart......
 
     
 
Date Format Title
Apr 14, 2010 Printer Friendly Version Presentation - Investor Conference April 2010
 
IR Contact
f
Ashley Ammon
or Christine Duan
ICR Inc.
Tel:1-203-682-8200
Email:ashley.ammon@icrinc.com; christine.duan@icrinc.com